{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:24:21Z","timestamp":1793931861048,"version":"4.8.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Canada Graduate Scholarship"},{"name":"Ontario Veterinary College Graduate Scholarship"},{"name":"Canada Vanier Graduate Scholarship"},{"name":"Brock Doctoral Scholarship"},{"name":"Canada First Research Excellence Fund (CFREF) Food from Thought funding"},{"name":"Office of the Vice-President of Research at the University of Guelph","award":["seed funding"],"award-info":[{"award-number":["seed funding"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-99248-6","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:08:50Z","timestamp":1746184130000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Cytokine, chemokine, and acute-phase protein profiles in plasma as correlative biomarkers of clinical outcomes for patients with COVID-19"],"prefix":"10.1038","volume":"15","author":[{"given":"Sierra G.","family":"Vanderkamp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maysa","family":"Niazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley A.","family":"Stegelmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Stinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Ricker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byram W.","family":"Bridle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,2]]},"reference":[{"key":"99248_CR1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature (London) 579, 270\u2013273 (2020).","journal-title":"Nature (London)"},{"key":"99248_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271-280.e278 (2020).","journal-title":"Cell"},{"key":"99248_CR3","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.molcel.2020.04.022","volume":"78","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M., Kleine-Weber, H. & P\u00f6hlmann, S. A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells. Mol. Cell 78, 779\u2013784 (2020).","journal-title":"Mol. Cell"},{"key":"99248_CR4","doi-asserted-by":"publisher","first-page":"2000607","DOI":"10.1183\/13993003.00607-2020","volume":"55","author":"RJ Mason","year":"2020","unstructured":"Mason, R. J. Pathogenesis of COVID-19 from a cell biology perspective. Eur. Respir. J. 55, 2000607 (2020).","journal-title":"Eur. Respir. J."},{"key":"99248_CR5","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"I Hamming","year":"2004","unstructured":"Hamming, I. et al. (2004) Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 203, 631\u2013637 (2004).","journal-title":"J. Pathol."},{"key":"99248_CR6","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41577-020-0343-0","volume":"20","author":"L-A Teuwen","year":"2020","unstructured":"Teuwen, L.-A., Geldhof, V., Pasut, A. & Carmeliet, P. COVID-19: The vasculature unleashed. Nat. Rev. Immunol. 20, 389\u2013391 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"99248_CR7","doi-asserted-by":"publisher","first-page":"100618","DOI":"10.1016\/j.cpcardiol.2020.100618","volume":"45","author":"S Zaim","year":"2020","unstructured":"Zaim, S., Chong, J. H., Sankaranarayanan, V. & Harky, A. COVID-19 and multiorgan response. Curr. Probl. Cardiol. 45, 100618\u2013100618 (2020).","journal-title":"Curr. Probl. Cardiol."},{"key":"99248_CR8","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/jmv.26232","volume":"93","author":"B Hu","year":"2021","unstructured":"Hu, B., Huang, S. & Yin, L. The cytokine storm and COVID-19. J. Med. Virol. 93, 250\u2013256 (2021).","journal-title":"J. Med. Virol."},{"key":"99248_CR9","first-page":"1564","volume":"75","author":"AK Azkur","year":"2020","unstructured":"Azkur, A. K. et al. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy (Copenhagen) 75, 1564\u20131581 (2020).","journal-title":"Allergy (Copenhagen)"},{"key":"99248_CR10","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","volume":"46","author":"Q Ruan","year":"2020","unstructured":"Ruan, Q., Yang, K., Wang, W., Jiang, L. & Song, J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 46, 846\u2013848 (2020).","journal-title":"Intensive Care Med"},{"key":"99248_CR11","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","volume":"584","author":"C Lucas","year":"2020","unstructured":"Lucas, C. et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature 584, 463\u2013469 (2020).","journal-title":"Nature"},{"key":"99248_CR12","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497\u2013506 (2020).","journal-title":"Lancet"},{"key":"99248_CR13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s10020-020-00230-x","volume":"26","author":"Y Chen","year":"2020","unstructured":"Chen, Y. et al. IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19. Mol. Med. 26, 97 (2020).","journal-title":"Mol. Med."},{"key":"99248_CR14","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/all.14657","volume":"76","author":"YD Gao","year":"2021","unstructured":"Gao, Y. D. et al. Risk factors for severe and critically ill COVID-19 patients: A review. Allergy 76, 428\u2013455 (2021).","journal-title":"Allergy"},{"key":"99248_CR15","doi-asserted-by":"publisher","first-page":"9478","DOI":"10.1111\/jcmm.15607","volume":"24","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. Systematic profiling of ACE2 expression in diverse physiological and pathological conditions for COVID-19\/SARS-CoV-2. J. Cell. Mol. Med. 24, 9478\u20139482 (2020).","journal-title":"J. Cell. Mol. Med."},{"key":"99248_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12929-020-00703-5","volume":"28","author":"IP Trougakos","year":"2021","unstructured":"Trougakos, I. P. et al. Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications. J. Biomed. Sci. 28, 9 (2021).","journal-title":"J. Biomed. Sci."},{"key":"99248_CR17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/00004872-200502000-00001","volume":"23","author":"H Brunner","year":"2005","unstructured":"Brunner, H. et al. Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the working group on endothelins and endothelial factors of the European society of hypertension. J. Hypertens. 23, 233\u2013246 (2005).","journal-title":"J. Hypertens."},{"key":"99248_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12872-015-0124-z","volume":"15","author":"JW Yau","year":"2015","unstructured":"Yau, J. W., Teoh, H. & Verma, S. Endothelial cell control of thrombosis. BMC Cardiovasc. Disord. 15, 130 (2015).","journal-title":"BMC Cardiovasc. Disord."},{"key":"99248_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.atherosclerosis.2020.10.014","volume":"314","author":"MP N\u00e4gele","year":"2020","unstructured":"N\u00e4gele, M. P., Haubner, B., Tanner, F. C., Ruschitzka, F. & Flammer, A. J. Endothelial dysfunction in COVID-19: Current findings and therapeutic implications. Atherosclerosis 314, 58\u201362 (2020).","journal-title":"Atherosclerosis"},{"key":"99248_CR20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/10408363.2020.1770685","volume":"57","author":"G Ponti","year":"2020","unstructured":"Ponti, G., Maccaferri, M., Ruini, C., Tomasi, A. & Ozben, T. Biomarkers associated with COVID-19 disease progression. Crit. Rev. Clin. Lab. Sci. 57, 389\u2013399 (2020).","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"99248_CR21","doi-asserted-by":"publisher","first-page":"857573","DOI":"10.3389\/fimmu.2022.857573","volume":"13","author":"D Battaglini","year":"2022","unstructured":"Battaglini, D., Lopes-Pacheco, M., Castro-Faria-Neto, H. C., Pelosi, P. & Rocco, P. R. M. Laboratory biomarkers for diagnosis and prognosis in COVID-19. Front. Immunol. 13, 857573 (2022).","journal-title":"Front. Immunol."},{"key":"99248_CR22","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen, N. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 395, 507\u2013513 (2020).","journal-title":"Lancet"},{"key":"99248_CR23","doi-asserted-by":"publisher","first-page":"764934","DOI":"10.3389\/fmed.2021.764934","volume":"8","author":"KY Lau","year":"2021","unstructured":"Lau, K. Y. et al. An unsupervised machine learning clustering and prediction of differential clinical phenotypes of COVID-19 patients based on blood tests\u2014A Hong Kong population study. Front. Med. (Lausanne) 8, 764934 (2021).","journal-title":"Front. Med. (Lausanne)"},{"key":"99248_CR24","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang, D. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. Jama 323, 1061\u20131069 (2020).","journal-title":"Jama"},{"key":"99248_CR25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12874-021-01254-5","volume":"21","author":"S Kanters","year":"2021","unstructured":"Kanters, S. et al. Comparing the use of aggregate data and various methods of integrating individual patient data to network meta-analysis and its application to first-line ART. BMC Med. Res. Methodol. 21, 60 (2021).","journal-title":"BMC Med. Res. Methodol."},{"key":"99248_CR26","doi-asserted-by":"publisher","first-page":"R34","DOI":"10.1186\/gb-2003-4-5-r34","volume":"4","author":"KY Yeung","year":"2003","unstructured":"Yeung, K. Y., Medvedovic, M. & Bumgarner, R. E. Clustering gene-expression data with repeated measurements. Genome Biol. 4, R34 (2003).","journal-title":"Genome Biol."},{"key":"99248_CR27","doi-asserted-by":"publisher","first-page":"8961","DOI":"10.1073\/pnas.161273698","volume":"98","author":"MK Kerr","year":"2001","unstructured":"Kerr, M. K. & Churchill, G. A. Bootstrapping cluster analysis: Assessing the reliability of conclusions from microarray experiments. Proc. Natl. Acad. Sci. 98, 8961\u20138965 (2001).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"99248_CR28","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/JCI137244","volume":"130","author":"G Chen","year":"2020","unstructured":"Chen, G. et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J. Clin. Invest. 130, 2620\u20132629 (2020).","journal-title":"J. Clin. Invest."},{"key":"99248_CR29","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1365-2567.2007.02555.x","volume":"120","author":"D Aw","year":"2007","unstructured":"Aw, D., Silva, A. B. & Palmer, D. B. Immunosenescence: emerging challenges for an ageing population. Immunology 120, 435\u2013446 (2007).","journal-title":"Immunology"},{"key":"99248_CR30","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.cell.2019.10.005","volume":"179","author":"V Gorgoulis","year":"2019","unstructured":"Gorgoulis, V. et al. Cellular senescence: Defining a path forward. Cell 179, 813\u2013827 (2019).","journal-title":"Cell"},{"key":"99248_CR31","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.3390\/cells10123367","volume":"10","author":"SM Lynch","year":"2021","unstructured":"Lynch, S. M., Guo, G., Gibson, D. S., Bjourson, A. J. & Rai, T. S. Role of senescence and aging in SARS-CoV-2 infection and COVID-19 disease. Cells 10, 3367 (2021).","journal-title":"Cells"},{"key":"99248_CR32","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.mad.2008.11.004","volume":"130","author":"KS Kim","year":"2009","unstructured":"Kim, K. S., Kang, K. W., Seu, Y. B., Baek, S. H. & Kim, J. R. Interferon-gamma induces cellular senescence through p53-dependent DNA damage signaling in human endothelial cells. Mech. Ageing Dev. 130, 179\u2013188 (2009).","journal-title":"Mech. Ageing Dev."},{"key":"99248_CR33","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.18632\/aging.101328","volume":"9","author":"R Kandhaya-Pillai","year":"2017","unstructured":"Kandhaya-Pillai, R. et al. TNF\u03b1-senescence initiates a STAT-dependent positive feedback loop, leading to a sustained interferon signature, DNA damage, and cytokine secretion. Aging (Albany NY) 9, 2411\u20132435 (2017).","journal-title":"Aging (Albany NY)"},{"key":"99248_CR34","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1093\/gerona\/glaa149","volume":"75","author":"S Salimi","year":"2020","unstructured":"Salimi, S. & Hamlyn, J. M. COVID-19 and crosstalk with the hallmarks of aging. J. Gerontol. A Biol. Sci. Med. Sci. 75, e34\u2013e41 (2020).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"99248_CR35","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","volume":"323","author":"Z Wu","year":"2020","unstructured":"Wu, Z. & McGoogan, J. M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA 323, 1239\u20131242 (2020).","journal-title":"JAMA"},{"key":"99248_CR36","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.ajem.2020.04.052","volume":"44","author":"A Santoso","year":"2021","unstructured":"Santoso, A. et al. Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: A meta-analysis. Am. J. Emerg. Med. 44, 352\u2013357 (2021).","journal-title":"Am. J. Emerg. Med."},{"key":"99248_CR37","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1136\/heartjnl-2020-317901","volume":"107","author":"S Bae","year":"2021","unstructured":"Bae, S., Kim, S. R., Kim, M. N., Shim, W. J. & Park, S. M. Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age: A systematic review and meta-analysis. Heart 107, 373\u2013380 (2021).","journal-title":"Heart"},{"key":"99248_CR38","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.cardfail.2009.01.014","volume":"15","author":"S Epelman","year":"2009","unstructured":"Epelman, S. et al. Soluble angiotensin-converting enzyme 2 in human heart failure: Relation with myocardial function and clinical outcomes. J. Card. Fail. 15, 565\u2013571 (2009).","journal-title":"J. Card. Fail."},{"key":"99248_CR39","doi-asserted-by":"publisher","first-page":"802228","DOI":"10.3389\/fphar.2022.802228","volume":"13","author":"H Hu","year":"2022","unstructured":"Hu, H. et al. Increased circulating cytokines have a role in COVID-19 severity and death with a more pronounced effect in males: A systematic review and meta-analysis. Front. Pharmacol. 13, 802228 (2022).","journal-title":"Front. Pharmacol."},{"key":"99248_CR40","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41586-020-2700-3","volume":"588","author":"T Takahashi","year":"2020","unstructured":"Takahashi, T. et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature 588, 315\u2013320 (2020).","journal-title":"Nature"},{"key":"99248_CR41","unstructured":"Docherty, A. et al. Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO clinical characterisation protocol. medRxiv, 2020.2004.2023.20076042 (2020)."},{"key":"99248_CR42","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s12016-017-8648-x","volume":"56","author":"S Jaillon","year":"2019","unstructured":"Jaillon, S., Berthenet, K. & Garlanda, C. Sexual dimorphism in innate immunity. Clin. Rev. Allergy Immunol. 56, 308\u2013321 (2019).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"99248_CR43","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3906\/sag-2011-32","volume":"51","author":"AB Gen\u00e7","year":"2021","unstructured":"Gen\u00e7, A. B. et al. The predictive and diagnostic accuracy of long pentraxin-3 in COVID-19 pneumonia. Turk. J. Med. Sci. 51, 448\u2013453 (2021).","journal-title":"Turk. J. Med. Sci."},{"key":"99248_CR44","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.3390\/biom11081136","volume":"11","author":"B Ku\u015bnierz-Cabala","year":"2021","unstructured":"Ku\u015bnierz-Cabala, B. et al. Diagnostic significance of serum Galectin-3 in hospitalized patients with COVID-19\u2014A preliminary study. Biomolecules 11, 1136 (2021).","journal-title":"Biomolecules"},{"key":"99248_CR45","doi-asserted-by":"publisher","first-page":"795315","DOI":"10.3389\/fimmu.2022.795315","volume":"13","author":"G Zizzo","year":"2022","unstructured":"Zizzo, G. et al. Immunotherapy of COVID-19: Inside and beyond IL-6 signalling. Front. Immunol. 13, 795315 (2022).","journal-title":"Front. Immunol."},{"key":"99248_CR46","doi-asserted-by":"publisher","first-page":"21697","DOI":"10.1038\/s41598-020-78710-7","volume":"10","author":"M J\u00f8ntvedt J\u00f8rgensen","year":"2020","unstructured":"J\u00f8ntvedt J\u00f8rgensen, M. et al. Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19. Sci. Rep. 10, 21697 (2020).","journal-title":"Sci. Rep."},{"key":"99248_CR47","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.immuni.2021.03.005","volume":"54","author":"PA Szabo","year":"2021","unstructured":"Szabo, P. A. et al. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19. Immunity 54, 797\u2013814 (2021).","journal-title":"Immunity"},{"key":"99248_CR48","doi-asserted-by":"publisher","first-page":"e144455","DOI":"10.1172\/jci.insight.144455","volume":"6","author":"MS Abers","year":"2021","unstructured":"Abers, M. S. et al. An immune-based biomarker signature is associated with mortality in COVID-19 patients. JCI Insight 6, e144455 (2021).","journal-title":"JCI Insight"},{"key":"99248_CR49","doi-asserted-by":"publisher","first-page":"107598","DOI":"10.1016\/j.intimp.2021.107598","volume":"101","author":"S Singh","year":"2021","unstructured":"Singh, S., Anshita, D. & Ravichandiran, V. MCP-1: Function, regulation, and involvement in disease. Int. Immunopharmacol. 101, 107598 (2021).","journal-title":"Int. Immunopharmacol."},{"key":"99248_CR50","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/BF01772208","volume":"126","author":"YS Li","year":"1993","unstructured":"Li, Y. S. et al. The expression of monocyte chemotactic protein (MCP-1) in human vascular endothelium in vitro and in vivo. Mol. Cell Biochem. 126, 61\u201368 (1993).","journal-title":"Mol. Cell Biochem."},{"key":"99248_CR51","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/bs.acc.2019.03.005","volume":"91","author":"A Zlibut","year":"2019","unstructured":"Zlibut, A., Bocsan, I. C. & Agoston-Coldea, L. Pentraxin-3 and endothelial dysfunction. Adv. Clin. Chem. 91, 163\u2013179 (2019).","journal-title":"Adv. Clin. Chem."},{"key":"99248_CR52","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.jinf.2020.01.010","volume":"80","author":"CB Hansen","year":"2020","unstructured":"Hansen, C. B. et al. Complement related pattern recognition molecules as markers of short-term mortality in intensive care patients. J. Infect. 80, 378\u2013387 (2020).","journal-title":"J. Infect."},{"key":"99248_CR53","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41590-020-00832-x","volume":"22","author":"E Brunetta","year":"2021","unstructured":"Brunetta, E. et al. Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19. Nat. Immunol. 22, 19\u201324 (2021).","journal-title":"Nat. Immunol."},{"key":"99248_CR54","doi-asserted-by":"publisher","first-page":"155637","DOI":"10.1016\/j.cyto.2021.155637","volume":"146","author":"N Todorovi\u0107-Rakovi\u0107","year":"2021","unstructured":"Todorovi\u0107-Rakovi\u0107, N. & Whitfield, J. R. Between immunomodulation and immunotolerance: The role of IFN\u03b3 in SARS-CoV-2 disease. Cytokine 146, 155637 (2021).","journal-title":"Cytokine"},{"key":"99248_CR55","unstructured":"Esquivel-Moynelo, I. I. et al. Effect and safety of combination of interferon alpha-2b and gamma or interferon alpha-2b for negativization of SARS-CoV-2 viral RNA. Preliminary results of a randomized controlled clinical trial. medRxiv, 2020.2007. 2029.20164251 (2020)."},{"key":"99248_CR56","doi-asserted-by":"crossref","unstructured":"Mendy, A., Apewokin, S., Wells, A. A. & Morrow, A. L. Factors associated with hospitalization and disease severity in a racially and ethnically diverse population of COVID-19 patients. medRxiv (2020).","DOI":"10.1101\/2020.06.25.20137323"},{"key":"99248_CR57","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3389\/fpsyg.2017.00456","volume":"8","author":"JZ Bakdash","year":"2017","unstructured":"Bakdash, J. Z. & Marusich, L. R. Repeated measures correlation. Front. Psychol. 8, 456 (2017).","journal-title":"Front. Psychol."},{"key":"99248_CR58","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/opo.12399","volume":"37","author":"RA Armstrong","year":"2017","unstructured":"Armstrong, R. A. Recommendations for analysis of repeated-measures designs: Testing and correcting for sphericity and use of manova and mixed model analysis. Ophthalmic Physiol. Opt. 37, 585\u2013593 (2017).","journal-title":"Ophthalmic Physiol. Opt."},{"key":"99248_CR59","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4103\/0975-9476.113872","volume":"4","author":"V Singh","year":"2013","unstructured":"Singh, V., Rana, R. K. & Singhal, R. Analysis of repeated measurement data in the clinical trials. J. Ayurveda Integr. Med. 4, 77\u201381 (2013).","journal-title":"J. Ayurveda Integr. Med."},{"key":"99248_CR60","unstructured":"Huang, Z. in Proceedings of the 1st Pacific-Asia Conference on Knowledge Discovery and Data Mining (PAKDD) 21\u201334 (Citeseer, 1997)."},{"key":"99248_CR61","unstructured":"Charrad, M., Ghazzali, N., Boiteau, V., Niknafs, A. NbClust: An R package for determining the relevant number of clusters in a data set."},{"key":"99248_CR62","unstructured":"MacQueen, J. in Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability 281\u2013297 (1967)."},{"key":"99248_CR63","doi-asserted-by":"publisher","first-page":"200","DOI":"10.32614\/RJ-2018-048","volume":"10","author":"G Szepannek","year":"2018","unstructured":"Szepannek, G. ClustMixType: User-friendly clustering of mixed-type data in R. R J. 10, 200 (2018).","journal-title":"R J."},{"key":"99248_CR64","doi-asserted-by":"publisher","first-page":"982","DOI":"10.21037\/atm-2020-57","volume":"8","author":"J Liang","year":"2020","unstructured":"Liang, J., Bi, G. & Zhan, C. Multinomial and ordinal Logistic regression analyses with multi-categorical variables using R. Ann. Transl. Med. 8, 982 (2020).","journal-title":"Ann. Transl. Med."},{"key":"99248_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v071.b03","volume":"71","author":"U Gr\u00f6mping","year":"2016","unstructured":"Gr\u00f6mping, U. Practical guide to logistic regression. J. Stat. Softw. 71, 1\u20135. https:\/\/doi.org\/10.18637\/jss.v071.b03 (2016).","journal-title":"J. Stat. Softw."},{"key":"99248_CR66","doi-asserted-by":"publisher","first-page":"9326","DOI":"10.1016\/j.eswa.2015.08.016","volume":"42","author":"ZY Algamal","year":"2015","unstructured":"Algamal, Z. Y. & Lee, M. H. Penalized logistic regression with the adaptive LASSO for gene selection in high-dimensional cancer classification. Expert Syst. Appl. 42, 9326\u20139332 (2015).","journal-title":"Expert Syst. Appl."},{"key":"99248_CR67","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0165-1765(03)00032-6","volume":"80","author":"C Ai","year":"2003","unstructured":"Ai, C. & Norton, E. C. Interaction terms in logit and probit models. Econ. Lett. 80, 123\u2013129 (2003).","journal-title":"Econ. Lett."},{"key":"99248_CR68","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1080\/03610920802592860","volume":"38","author":"A Esteve","year":"2009","unstructured":"Esteve, A., Boj, E. & Fortiana, J. Interaction terms in distance-based regression. Commun. Stat. Theory Methods 38, 3498\u20133509 (2009).","journal-title":"Commun. Stat. Theory Methods"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99248-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99248-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99248-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T13:25:10Z","timestamp":1746192310000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99248-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["99248"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-99248-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,2]]},"assertion":[{"value":"28 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"B.W.B. is a Scientific Advisor for ImmunoCeutica Inc. (ICI), which is dedicated to the research and development of immunoceuticals. ICI was not involved in any way with this manuscript and the research it describes. B.W.B. has received honoraria for speaking engagements and has given paid expert testimony in service to courts for his expertise in viral immunology. The other authors have no potential conflicts of interest to declare. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15397"}}